This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Compared to Estimates, Clorox (CLX) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Clorox (CLX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Clorox (CLX) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of +28.12% and +3.04%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Countdown to Clorox (CLX) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Clorox (CLX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Clorox Pre-Q4 Earnings Send Mixed Signals: Time to Accumulate Shares?
by Zacks Equity Research
CLX's Q4 performance is likely to have benefited from margin strength and innovation, but macro headwinds and rising costs keep investors cautious.
Analysts Estimate Colgate-Palmolive (CL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (CLX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ADRNY vs. CLX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ADRNY vs. CLX: Which Stock Is the Better Value Option?
Primoris Services and Clorox have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Primoris Services is surging on infrastructure megatrends, while Clorox faces weak earnings and fading pandemic-era momentum.
Bear of the Day: The Clorox Company (CLX)
by Benjamin Rains
The maker of disinfectant wipes and beyond has seen its earnings outlook fade again recently, and its revenue is projected to dip in FY25 and FY26.
Can Clorox's Pricing Strength Keep Earnings Buoyant in 2025?
by Zacks Equity Research
CLX leverages targeted pricing, cost cuts and premiumization to boost margins despite soft volume trends.
Can Colgate's Pricing Strength Keep Earnings Buoyant in 2025?
by Zacks Equity Research
CL's strategic pricing, margin gains and productivity moves support steady EPS growth into 2025 despite cost pressures.
ADRNY or CLX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ADRNY vs. CLX: Which Stock Is the Better Value Option?
Is Clorox's International Expansion Key to Its Long-Term Success?
by Zacks Equity Research
CLX bets on global growth as it expands in Latin America and Asia, aiming to offset slowing U.S. sales with long-term international gains.
Newell's Smart Productivity Moves Likely to Offset Cost Pressures
by Zacks Equity Research
NWL boosts profitability through productivity gains, automation, cost control and strategic supply-chain improvements.
Is the Options Market Predicting a Spike in Clorox Stock?
by Zacks Equity Research
Investors need to pay close attention to CLX stock based on the movements in the options market lately.
Can Procter & Gamble's Pricing Power Keep Earnings Buoyant in 2025?
by Zacks Equity Research
PG leverages value-based pricing and innovation to enhance consumer value, profits and market share.
ADRNY vs. CLX: Which Stock Is the Better Value Option?
by Zacks Equity Research
ADRNY vs. CLX: Which Stock Is the Better Value Option?
Colgate Taps Productivity Plan, Enhances Profits, Protects Margins
by Zacks Equity Research
CL streamlines supply chain, modernizes manufacturing and cuts overhead to boost efficiency and execution.
Clorox's Innovation Strategy Elevates Everyday Essentials
by Zacks Equity Research
CLX leans on premium innovation and smart pricing to protect market share and margins amid shifting consumer demand.
Are PG's Beauty and Health Units Driving the Next Leg of Growth?
by Zacks Equity Research
Procter & Gamble drives global well-being through product innovation and CSR across health, hygiene and cleaning.
Zacks Industry Outlook Highlights Colgate-Palmolive, The Clorox, BJ's Wholesale Club and Grocery Outlet
by Zacks Equity Research
Colgate, Clorox, BJ's, and Grocery Outlet lean on innovation, pricing, and digital upgrades to stay resilient amid cost pressures.
CLX's Productivity Drive: Likely to Aid Margins & Offset High Costs?
by Zacks Equity Research
Clorox sharpens its productivity edge with digital tools, empowered teams and a leaner operating model for agile growth.
4 Resilient Consumer Product Stocks to Monitor in a Challenging Market
by Ansuiya Mohta
CL, CLX, BJ and GO remain resilient as they navigate rising costs and shifting consumer trends with strategic moves.
PG's Productivity Drive: Enough to Offset FX and Cost Pressures?
by Zacks Equity Research
Procter & Gamble leans on productivity investments to offset inflation and currency swings, aiming to protect and grow margins.
ADRNY or CLX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ADRNY vs. CLX: Which Stock Is the Better Value Option?